Corvus Pharmaceuticals (CRVS) PT Lowered to $11 at Mizuho
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh lowered the price target on Corvus Pharmaceuticals (NASDAQ: CRVS) to $11.00 (from $12.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
